{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T19:02:59Z","timestamp":1745262179029,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T00:00:00Z","timestamp":1478822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00432-016-2298-x","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T05:50:59Z","timestamp":1478843459000},"page":"369-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer and hereditary haemorrhagic telangiectasia"],"prefix":"10.1007","volume":"143","author":[{"given":"A. E.","family":"Hosman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-5775","authenticated-orcid":false,"given":"C. L.","family":"Shovlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,11]]},"reference":[{"issue":"1","key":"2298_CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1158\/1055-9965.EPI-13-0665","volume":"23","author":"CW Duarte","year":"2014","unstructured":"Duarte CW, Murray K, Lucas FL, Fairfield K, Miller H, Brooks P, Vary CP (2014) Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia. Cancer Epidemiol Biomark Prev 23(1):117\u2013125","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2298_CR2","doi-asserted-by":"crossref","unstructured":"Duarte CW, Black AW, Lucas FL, Vary CP (2016) Cancer incidence in patients with hereditary hemorrhagic telangiectasia. J Cancer Res Clin Oncol (Epub ahead of print)","DOI":"10.1007\/s00432-016-2272-7"},{"key":"2298_CR3","unstructured":"GLOBOCAN (2008) Estimated cancer incidence, mortality, prevalence and disability-adjusted life years (DALYs) worldwide in 2008. http:\/\/globocan.iarc.fr . Globocan 2012. Accessed 17 Oct 2016"},{"issue":"2","key":"2298_CR4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.carj.2013.02.007","volume":"65","author":"K Hanneman","year":"2014","unstructured":"Hanneman K, Faughnan ME, Prabhudesai V (2014) Cumulative radiation dose in patients with hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations. Can Assoc Radiol J 65(2):135\u2013140","journal-title":"Can Assoc Radiol J"},{"issue":"8","key":"2298_CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1750-1172-8-195","volume":"20","author":"AE Hosman","year":"2013","unstructured":"Hosman AE, Devlin HL, Silva BM, Shovlin CL (2013) Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls. Orphanet J Rare Dis 20(8):195","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2298_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/cge.12693","volume":"90","author":"AM Jelsig","year":"2016","unstructured":"Jelsig AM, T\u00f8rring PM, Kjeldsen AD, Qvist N, Bojesen A, Jensen UB, Andersen MK, Gerdes AM, Brusgaard K, Ousager LB (2016) JP-HHT phenotype in Danish patients with SMAD4 mutations. Clin Genet 90(1):55\u201362","journal-title":"Clin Genet"},{"key":"2298_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","volume":"245","author":"AD Kjeldsen","year":"1999","unstructured":"Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245:31\u201339","journal-title":"J Intern Med"},{"issue":"2","key":"2298_CR8","doi-asserted-by":"crossref","first-page":"e0147990","DOI":"10.1371\/journal.pone.0147990","volume":"11","author":"IG Mollet","year":"2016","unstructured":"Mollet IG, Patel D, Govani FS, Giess A, Paschalaki K, Periyasamy M, Lidington EC, Mason JC, Jones MD, Game L, Ali S, Shovlin CL (2016) Low dose iron treatments induce a DNA damage response in human endothelial cells within minutes. PLoS ONE 11(2):e0147990","journal-title":"PLoS ONE"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2298-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-016-2298-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2298-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:22:53Z","timestamp":1498346573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-016-2298-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,11]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2298"],"URL":"https:\/\/doi.org\/10.1007\/s00432-016-2298-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2016,11,11]]}}}